Northland Capmk Brokers Boost Earnings Estimates for Hyliion

Hyliion Holdings Corp. (NYSE:HYLN) – Equities research analysts at Northland Capmk upped their FY2025 earnings per share estimates for shares of Hyliion in a research report issued to clients and investors on Thursday, November 13th. Northland Capmk analyst E. Jackson now anticipates that the company will post earnings of ($0.33) per share for the year, up from their previous forecast of ($0.34). The consensus estimate for Hyliion’s current full-year earnings is ($0.28) per share. Northland Capmk also issued estimates for Hyliion’s Q3 2026 earnings at ($0.08) EPS, Q4 2026 earnings at ($0.07) EPS, FY2026 earnings at ($0.31) EPS and FY2027 earnings at ($0.36) EPS.

Other equities research analysts have also issued reports about the stock. Wall Street Zen upgraded shares of Hyliion from a “sell” rating to a “hold” rating in a report on Saturday. Zacks Research raised Hyliion from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 13th. Finally, Johnson Rice began coverage on Hyliion in a research note on Tuesday, October 21st. They issued a “buy” rating and a $5.00 price objective on the stock. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $5.00.

Hyliion Stock Performance

NYSE HYLN opened at $1.64 on Monday. The firm has a market cap of $287.72 million, a price-to-earnings ratio of -4.43 and a beta of 2.35. The firm has a 50 day simple moving average of $2.07 and a 200-day simple moving average of $1.72. Hyliion has a one year low of $1.11 and a one year high of $4.10.

Insider Transactions at Hyliion

In other news, Director Richard Joseph Freeland purchased 65,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The stock was bought at an average price of $1.57 per share, for a total transaction of $102,050.00. Following the completion of the purchase, the director directly owned 222,798 shares of the company’s stock, valued at $349,792.86. The trade was a 41.19% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 20.90% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Hyliion

A number of hedge funds and other institutional investors have recently modified their holdings of the company. SG Americas Securities LLC acquired a new position in shares of Hyliion during the third quarter worth $27,000. Cubist Systematic Strategies LLC purchased a new stake in Hyliion during the 1st quarter worth about $26,000. Banco BTG Pactual S.A. purchased a new stake in Hyliion during the 3rd quarter worth about $37,000. O ROURKE & COMPANY Inc boosted its position in shares of Hyliion by 50.0% during the 3rd quarter. O ROURKE & COMPANY Inc now owns 20,006 shares of the company’s stock worth $39,000 after acquiring an additional 6,670 shares in the last quarter. Finally, Brevan Howard Capital Management LP purchased a new position in shares of Hyliion in the 2nd quarter valued at about $30,000. 22.81% of the stock is currently owned by institutional investors and hedge funds.

About Hyliion